1. Home
  2. ABCL vs QNST Comparison

ABCL vs QNST Comparison

Compare ABCL & QNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABCL
  • QNST
  • Stock Information
  • Founded
  • ABCL 2012
  • QNST 1999
  • Country
  • ABCL Canada
  • QNST United States
  • Employees
  • ABCL N/A
  • QNST N/A
  • Industry
  • ABCL Biotechnology: Pharmaceutical Preparations
  • QNST Business Services
  • Sector
  • ABCL Health Care
  • QNST Consumer Discretionary
  • Exchange
  • ABCL Nasdaq
  • QNST Nasdaq
  • Market Cap
  • ABCL 1.1B
  • QNST 923.2M
  • IPO Year
  • ABCL 2020
  • QNST 2010
  • Fundamental
  • Price
  • ABCL $4.24
  • QNST $16.25
  • Analyst Decision
  • ABCL Strong Buy
  • QNST Strong Buy
  • Analyst Count
  • ABCL 5
  • QNST 7
  • Target Price
  • ABCL $8.75
  • QNST $28.29
  • AVG Volume (30 Days)
  • ABCL 6.7M
  • QNST 495.9K
  • Earning Date
  • ABCL 08-07-2025
  • QNST 08-07-2025
  • Dividend Yield
  • ABCL N/A
  • QNST N/A
  • EPS Growth
  • ABCL N/A
  • QNST N/A
  • EPS
  • ABCL N/A
  • QNST N/A
  • Revenue
  • ABCL $23,114,000.00
  • QNST $1,029,978,000.00
  • Revenue This Year
  • ABCL N/A
  • QNST $80.76
  • Revenue Next Year
  • ABCL $71.11
  • QNST $7.94
  • P/E Ratio
  • ABCL N/A
  • QNST N/A
  • Revenue Growth
  • ABCL N/A
  • QNST 88.81
  • 52 Week Low
  • ABCL $1.89
  • QNST $14.39
  • 52 Week High
  • ABCL $5.82
  • QNST $26.27
  • Technical
  • Relative Strength Index (RSI)
  • ABCL 50.27
  • QNST 54.27
  • Support Level
  • ABCL $4.67
  • QNST $16.10
  • Resistance Level
  • ABCL $5.19
  • QNST $16.48
  • Average True Range (ATR)
  • ABCL 0.40
  • QNST 0.54
  • MACD
  • ABCL -0.09
  • QNST 0.05
  • Stochastic Oscillator
  • ABCL 18.97
  • QNST 65.08

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

About QNST QuinStreet Inc.

QuinStreet Inc focuses on marketplaces and technologies for the financial services and home services industries. It delivers measurable and cost-effective marketing results to its clients, in the form of qualified inquiries such as clicks, leads, calls, applications, or customers. It generates revenue by delivering measurable online marketing results to the clients. Its products and services are Customer Acquisition, QuinStreet Rating Platform (QRP), and CloudControlMedia.

Share on Social Networks: